# FDA recall D-0077-2023

> **RemedyRepack Inc.** · Class II · drug recall initiated 2022-12-05.

## Product

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ  08816; Repackaged by: RemedyRepack Inc., Indiana, PA  15701, NDC #: 70518-3493-00.

## Reason for recall

Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

## Distribution

Product was distributed to two different customers in MI.

## Key facts

- **Recall number:** D-0077-2023
- **Recalling firm:** RemedyRepack Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-05
- **Report date:** 2022-12-14
- **Termination date:** 2023-02-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Indiana, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0077-2023

## Citation

> AI Analytics. FDA recall D-0077-2023. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0077-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*